Glycemic control with use of insulin glargine after cardiothoracic surgery: A retrospective study

Endocrine Practice

Volumn 19, Issue 3, 2013, Pages 485-493

  Ergin, Ahmet Bahadir ^a   Nasr, Gaelle ^b   Yared, Jean Pierre ^a   Bena, James ^a   Nasr, Christian ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN GLARGINE; RECOMBINANT HUMAN INSULIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN INFUSION; INSULIN TREATMENT; MALE; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; THORAX SURGERY;

EID: 84880125020     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP12404.OR     Document Type: Article

References (25)

1. Van den Berghe G, Mesotten D, Vanhorebeek I. Intensive insulin therapy i. The intensive care unit. CMAJ. 2009;180:799-800.
2. Ascione R, Rogers CA, Rajakaruna C, Angelini GD. Inadequate blood glucose control is associated with in-hospital mortality and morbidity in diabetic and nondiabetic patients undergoing cardiac surgery. Circulation. 2008;118:113-123.
3. Furnary AP, Gao G, Grunkemeier GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125:1007-1021
4. Lazar HL. Hyperglycemia during cardiac surgery. J Thorac Cardiovasc Surg. 2006;131:11-13.
5. Killian M, Russell AC, Keister KJ. Prevention of sternal wound infections after coronary artery bypass graft surgery with use of insulin drug therapy: a review o. The literature. Dimens Crit Care Nurs. 2009;28:199-203.
6. Golden SH, Peart-Vigilance C, Kao WH, Brancati FL. Perioperative glycemic control an. The risk of infectious complications in a cohort of adults with diabetes. Diabetes Care. 1999;22:1408-1414.
7. Gandhi GY, Nuttall GA, Abel MD, et al. Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clin Proc. 2005;80:862-866.
8. Carvalho G, Schricker T. Letter regarding article by Lazar et al, 'Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events': response. Circulation. 2004;110:e505.
9. Olansky L, Sam S, Lober C, Yared JP, Hoogwerf B. Cleveland clinic cardiovascular intensive care unit insulin conversion protocol. J Diabetes Sci Technol. 2009;3: 478-486.
10. McAlister FA, Man J, Bistritz L, Amad H, Tandon P. Diabetes and coronary artery bypass surgery: an examination of perioperative glycemic control and outcomes. Diabetes Care. 2003;26:1518-1524.
11. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87:978-982.
12. Fish LH, Weaver TW, Moore AL, Steel LG. Value of postoperative blood glucose in predicting complications and length of stay after coronary artery bypass grafting. Am J Cardiol. 2003;92:74-76.
13. Guvener M, Pasaoglu I, Demircin M, Oc M. Perioperative hyperglycemia is a strong correlate of postoperative infection in type II diabetic patients after coronary artery bypass grafting. Endocr J. 2002;49:531-537.
14. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001; 345:1359-1367.
15. Furnary AP, Wu Y. Clinical effects of hyperglycemia i. The cardiac surgery population. The Portland Diabetic Project. Endocr Pract. 2006;12(suppl 3):22-26.
16. Doenst T, Wijeysundera D, Karkouti K, et al. Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg. 2005;130:1144.
17. Furnary AP, Braithwaite SS. Effects of outcome on in-hospital transition from intravenous insulin infusion to subcutaneous therapy. Am J Cardiol. 2006;98:557-564.
18. Markovitz LJ, Wiechmann RJ, Harris N, et al. Description and evaluation of a glycemic management protocol for patients with diabetes undergoing heart surgery. Endocr Pract. 2002;8:10-18.
19. Schmeltz LR, DeSantis AJ, Schmidt K, et al. Conversion of intravenous insulin infusions to subcutaneously administered insulin glargine in patients with hyperglycemia. Endocr Pract. 2006;12:641-650.
20. DeSantis AJ, Schmeltz LR, Schmidt K, et al. Inpatient management of hyperglycemia: The Northwestern experience. Endocr Pract. 2006;12:491-505.
21. Bode BW, Braithwaite SS, Steed RD, Davidson PC. Intravenous insulin infusion therapy: Indications, methods, and transition to subcutaneous insulin therapy. Endocr Pract. 2004;10(suppl 2):71-80.
22. Liao P, DeSantis AJ, Schmeltz LR, et al. Insulin resistance following cardiothoracic surgery in patients with and without a preoperative diagnosis of type 2 diabetes during treatment with intravenous insulin therapy for postoperative hyperglycemia. J Diabetes Complications. 2008;22: 229-234.
23. Sawin G, Shaughnessy AF. Glucose control in hospitalized patients. Am Fam Physician. 2010;81:1121-1124.
24. Kato M, Akao M, Iguchi M, Nobuyoshi M, Kimura T. Abstract 18031: Impact of diabetes and acute hyperglycemia on myocardial ischemia/reperfusion injury and ischemic preconditioning: evidence from real-time two-photon imaging. Circulation. 2010;122(suppl 1):A18031.
25. Ferrannini E. Santoro D. Bonadonna R. Natali A. Parodi O. Camici P.G. Metabolic and hemodynamic effects of insulin on human hearts Am J Physiol 1993.